Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage

Completed

Phase 2 Results

Summary of Purpose

To test the safety of a range of doses of tirlazad mesylate in patients with aneurysmal subarachnoid hemorrhage (SAH) and to gain pilot information for use in efficacy trials.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pharamacia-Upjohn, Inc., Kalamazoo, MI

Trial Design

Randomized, double-blind, vehicle-controlled, dose-escalation study of 245 patients at 12 Canadian centers.

Contacts

  • E. Clarke Haley, Jr., M.D., Department of Neurology, University of Virginia Health Sciences Center, Box 394, Charlottesville, VA 22908.

    ech@virginia.edu